The Blood Grouping Reagents Market in Portugal was valued at 8.1409 million USD in 2023. Over the past decade, the market has experienced a significant decline. In the last two years, the market witnessed a year-on-year decrease of 10.07% in 2022 and 11.08% in 2023, indicating persistent contraction. Analyzing a longer period, the compound annual growth rate (CAGR) shows a consistent downturn of approximately 7% over the last five years.
Future trends to watch for include advancements in blood grouping technologies and potential market recovery driven by increased healthcare investments and innovations in diagnostic tools. Monitoring regulatory changes and adoption of new testing techniques will be crucial in forecasting market dynamics.
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | View data |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | View data |
| 9 | 9 Australia | 10,169,000 | 2023 | -9.35% | -7.54% | View data |
| 10 | 10 Hungary | 8,505,100 | 2023 | +0.8% | -2.77% | View data |
| 11 | 11 Portugal | 8,140,900 | 2023 | -11.08% | -6.98% | |
| 12 | 12 Belgium | 7,578,800 | 2023 | -0.5% | -2.57% | View data |
| 13 | 13 Croatia | 4,027,100 | 2023 | -3.49% | -1.48% | View data |
